Quantitative measurement of postural sway in mouse models of human neurodegenerative disease

D. Hutchinson, V. Ho, M. Dodd, H. N. Dawson, A. C. Zumwalt, D. Schmitt, C. A. Colton

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Detection of motor dysfunction in genetic mouse models of neurodegenerative disease requires reproducible, standardized and sensitive behavioral assays. We have utilized a center of pressure (CoP) assay in mice to quantify postural sway produced by genetic mutations that affect motor control centers of the brain. As a positive control for postural instability, wild type mice were injected with harmaline, a tremorigenic agent, and the average areas of the 95% confidence ellipse, which measures 95% of the CoP trajectory values recorded in a single trial, were measured. Ellipse area significantly increased in mice treated with increasing doses of harmaline and returned to control values after recovery. We also examined postural sway in mice expressing mutations that mimic frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) (T-279, P301L or P301L-nitric oxide synthase 2 (NOS2)-/- mice) and that demonstrate motor symptoms. These mice were then compared with a mouse model of Alzheimer's disease (APPSwDI mice) that demonstrates cognitive, but not motor deficits. T-279 and P301L-NOS2-/- mice demonstrated a significant increase in CoP ellipse area compared with appropriate wild type control mice or to mice expressing the P301L mutation alone. In contrast, postural instability was significantly reduced in APPSwDI mice that have cognitive deficits but do not have associated motor deficits. The CoP assay provides a simple, sensitive and quantitative tool to detect motor deficits resulting from postural abnormalities in mice and may be useful in understanding the underlying mechanisms of disease.

Original languageEnglish
Pages (from-to)825-832
Number of pages8
JournalNeuroscience
Volume148
Issue number4
DOIs
Publication statusPublished - 21 Sep 2007
Externally publishedYes

Fingerprint

Neurodegenerative Diseases
Harmaline
Pressure
Frontotemporal Dementia
Nitric Oxide Synthase
Mutation
Chromosomes, Human, Pair 17
Genetic Models
Alzheimer Disease

Keywords

  • behavior
  • center of pressure assay
  • models
  • neurodegeneration
  • postural sway
  • tremor

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Hutchinson, D., Ho, V., Dodd, M., Dawson, H. N., Zumwalt, A. C., Schmitt, D., & Colton, C. A. (2007). Quantitative measurement of postural sway in mouse models of human neurodegenerative disease. Neuroscience, 148(4), 825-832. https://doi.org/10.1016/j.neuroscience.2007.07.025

Quantitative measurement of postural sway in mouse models of human neurodegenerative disease. / Hutchinson, D.; Ho, V.; Dodd, M.; Dawson, H. N.; Zumwalt, A. C.; Schmitt, D.; Colton, C. A.

In: Neuroscience, Vol. 148, No. 4, 21.09.2007, p. 825-832.

Research output: Contribution to journalArticle

Hutchinson, D, Ho, V, Dodd, M, Dawson, HN, Zumwalt, AC, Schmitt, D & Colton, CA 2007, 'Quantitative measurement of postural sway in mouse models of human neurodegenerative disease' Neuroscience, vol. 148, no. 4, pp. 825-832. https://doi.org/10.1016/j.neuroscience.2007.07.025
Hutchinson, D. ; Ho, V. ; Dodd, M. ; Dawson, H. N. ; Zumwalt, A. C. ; Schmitt, D. ; Colton, C. A. / Quantitative measurement of postural sway in mouse models of human neurodegenerative disease. In: Neuroscience. 2007 ; Vol. 148, No. 4. pp. 825-832.
@article{1bd08816755e46a585206903174bded8,
title = "Quantitative measurement of postural sway in mouse models of human neurodegenerative disease",
abstract = "Detection of motor dysfunction in genetic mouse models of neurodegenerative disease requires reproducible, standardized and sensitive behavioral assays. We have utilized a center of pressure (CoP) assay in mice to quantify postural sway produced by genetic mutations that affect motor control centers of the brain. As a positive control for postural instability, wild type mice were injected with harmaline, a tremorigenic agent, and the average areas of the 95{\%} confidence ellipse, which measures 95{\%} of the CoP trajectory values recorded in a single trial, were measured. Ellipse area significantly increased in mice treated with increasing doses of harmaline and returned to control values after recovery. We also examined postural sway in mice expressing mutations that mimic frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) (T-279, P301L or P301L-nitric oxide synthase 2 (NOS2)-/- mice) and that demonstrate motor symptoms. These mice were then compared with a mouse model of Alzheimer's disease (APPSwDI mice) that demonstrates cognitive, but not motor deficits. T-279 and P301L-NOS2-/- mice demonstrated a significant increase in CoP ellipse area compared with appropriate wild type control mice or to mice expressing the P301L mutation alone. In contrast, postural instability was significantly reduced in APPSwDI mice that have cognitive deficits but do not have associated motor deficits. The CoP assay provides a simple, sensitive and quantitative tool to detect motor deficits resulting from postural abnormalities in mice and may be useful in understanding the underlying mechanisms of disease.",
keywords = "behavior, center of pressure assay, models, neurodegeneration, postural sway, tremor",
author = "D. Hutchinson and V. Ho and M. Dodd and Dawson, {H. N.} and Zumwalt, {A. C.} and D. Schmitt and Colton, {C. A.}",
year = "2007",
month = "9",
day = "21",
doi = "10.1016/j.neuroscience.2007.07.025",
language = "English",
volume = "148",
pages = "825--832",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Quantitative measurement of postural sway in mouse models of human neurodegenerative disease

AU - Hutchinson, D.

AU - Ho, V.

AU - Dodd, M.

AU - Dawson, H. N.

AU - Zumwalt, A. C.

AU - Schmitt, D.

AU - Colton, C. A.

PY - 2007/9/21

Y1 - 2007/9/21

N2 - Detection of motor dysfunction in genetic mouse models of neurodegenerative disease requires reproducible, standardized and sensitive behavioral assays. We have utilized a center of pressure (CoP) assay in mice to quantify postural sway produced by genetic mutations that affect motor control centers of the brain. As a positive control for postural instability, wild type mice were injected with harmaline, a tremorigenic agent, and the average areas of the 95% confidence ellipse, which measures 95% of the CoP trajectory values recorded in a single trial, were measured. Ellipse area significantly increased in mice treated with increasing doses of harmaline and returned to control values after recovery. We also examined postural sway in mice expressing mutations that mimic frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) (T-279, P301L or P301L-nitric oxide synthase 2 (NOS2)-/- mice) and that demonstrate motor symptoms. These mice were then compared with a mouse model of Alzheimer's disease (APPSwDI mice) that demonstrates cognitive, but not motor deficits. T-279 and P301L-NOS2-/- mice demonstrated a significant increase in CoP ellipse area compared with appropriate wild type control mice or to mice expressing the P301L mutation alone. In contrast, postural instability was significantly reduced in APPSwDI mice that have cognitive deficits but do not have associated motor deficits. The CoP assay provides a simple, sensitive and quantitative tool to detect motor deficits resulting from postural abnormalities in mice and may be useful in understanding the underlying mechanisms of disease.

AB - Detection of motor dysfunction in genetic mouse models of neurodegenerative disease requires reproducible, standardized and sensitive behavioral assays. We have utilized a center of pressure (CoP) assay in mice to quantify postural sway produced by genetic mutations that affect motor control centers of the brain. As a positive control for postural instability, wild type mice were injected with harmaline, a tremorigenic agent, and the average areas of the 95% confidence ellipse, which measures 95% of the CoP trajectory values recorded in a single trial, were measured. Ellipse area significantly increased in mice treated with increasing doses of harmaline and returned to control values after recovery. We also examined postural sway in mice expressing mutations that mimic frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) (T-279, P301L or P301L-nitric oxide synthase 2 (NOS2)-/- mice) and that demonstrate motor symptoms. These mice were then compared with a mouse model of Alzheimer's disease (APPSwDI mice) that demonstrates cognitive, but not motor deficits. T-279 and P301L-NOS2-/- mice demonstrated a significant increase in CoP ellipse area compared with appropriate wild type control mice or to mice expressing the P301L mutation alone. In contrast, postural instability was significantly reduced in APPSwDI mice that have cognitive deficits but do not have associated motor deficits. The CoP assay provides a simple, sensitive and quantitative tool to detect motor deficits resulting from postural abnormalities in mice and may be useful in understanding the underlying mechanisms of disease.

KW - behavior

KW - center of pressure assay

KW - models

KW - neurodegeneration

KW - postural sway

KW - tremor

UR - http://www.scopus.com/inward/record.url?scp=34548686801&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2007.07.025

DO - 10.1016/j.neuroscience.2007.07.025

M3 - Article

VL - 148

SP - 825

EP - 832

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 4

ER -